





































































Membrane vesicles from the probiotic Nissle 1917 and gut 
resident Escherichia coli strains distinctly modulate human 
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Extracellular membrane vesicles (MVs) released by gut microbiota are key players in 2 
the communication with the host. The aim of this study was to evaluate the 3 
immunomodulatory properties of MVs from the probiotic E. coli Nissle 1917 (EcN) in 4 
terms of DC-derived adaptative immune responses and to compare the effects with 5 
those elicited by commensal E. coli. The effects of MVs were analysed in monocyte-6 
derived DCs by measuring cytokine expression and the ability of activated-DCs to 7 
differentiate CD4+ T cells towards specific effector subsets. EcN MVs drived intricated 8 
Th1/Th2/Th17/Th22/Treg responses consistent with the beneficial effects of this 9 
probiotic. Th2/Th17/Th22 responses were common to commensal E. coli-derived 10 
vesicles but specific differences were observed for Th1 and Treg responses. Since MVs 11 
activate DCs in a strain-specific manner, probiotic-derived MVs could be explored as a 12 
safe (bacteria-free) strategy to develop new functional food ingredients targeting gut 13 
microbiota balance or intestinal inflammation.  14 
 15 
Key words: Escherichia coli, Nissle 1917, gut microbiota, dendritic cells, membrane 16 
vesicles, innate immunity  17 
 18 
Abbreviations: DCs: dendritic cells, DMEM: Dulbecco’s modified Eagle medium, 19 
EcN: Escherichia coli Nissle 1917, FBS: foetal bovine serum, HPRT-1 hypoxanthine 20 
phosphoribosyl transferase, iDCs: immature DCs, LB: Luria-Bertani broth, LPS: 21 
lipopolysaccharide, MAMPs: microbial-associated molecular patterns, mDCs, mature 22 
DCs, Mo-DCs: monocyte-derived DCs, MFI: mean fluorescence intensity, MTT: 3-23 
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, MVs: membrane vesicles, 24 
NLR: NOD-like receptor, NOD: nucleotide oligomerization domain, OMVs: outer 25 
membrane vesicles, PBS: phosphate buffer saline; PRR: pattern recognition receptor, 26 
RT-qPCR: quantitative reverse transcription PCR, TEM: transmission electron 27 




































































1. Introduction 29 
The human gastrointestinal tract is colonized by a diverse and complex 30 
microbial community known as gut microbiota, which is essential to intestinal 31 
homeostasis and human health. Besides its contribution to food digestion and nutrient 32 
metabolism, gut microbiota plays a pivotal role in host immune system development 33 
and in the modulation of gut barrier, immune and defence responses (Jandhyala et al., 34 
2015; Thursby & Juge, 2017). Variations in microbiota composition and diversity 35 
(dysbiosis) may disturb host balanced responses and contribute to a wide variety of 36 
diseases including cancer and inflammatory, autoimmune, metabolic and neurological 37 
disorders (Belkaid & Hand, 2014; Gopalakrishnan et al., 2018; Baothman et al., 2016; 38 
Marin et al., 2017). The high plasticity of the human microbiome provides the basis for 39 
new therapeutic strategies aimed at restoring altered gut microbiota balance (Jia et al., 40 
2008; Shanahan, 2011; Maguire & Maguire, 2018). Administration of probiotics is one 41 
of these therapeutic interventions, which essentially attempts to take advantage of the 42 
beneficial effects of commensal microbiota. 43 
Gut microbiota establishes dynamic, reciprocal interactions with the intestinal 44 
epithelium and the immune system. This complex network orchestrates appropriate 45 
immune responses that protect against enteric pathogens while maintaining tolerance to 46 
symbiotic microbiota and innocuous antigens. Constant stimulation of the intestinal 47 
immune system by commensal microbiota tightly regulates innate and adaptive 48 
responses, leading to controlled inflammatory responses that contribute to the training 49 
of immune system. Immune priming by microbiota is an essential mechanism to trigger 50 
appropriate immune responses against invading microbes to assist pathogen eradication 51 
and host survival (Belkaid & Hand, 2014; Caballero & Pamer, 2015).  52 
The ability of intestinal cells to discriminate between pathogens and commensals 53 
is key to intestinal homeostasis. Dendritic cells (DCs) in the lamina propria play a 54 
pivotal role in sampling gut microbes and shaping appropriate immune responses. In 55 
fact, DCs serve as the cellular link between innate and adaptive responses. DCs are 56 
antigen-presenting cells that can contact the luminal environment through the inner 57 
mucosal lining. Recognition of gut microbes by these phagocytic cells depends on the 58 
expression of pattern-recognition receptors (PRRs) that interact with specific microbial 59 
components, known as microbial-associated molecular patterns (MAMPs). Upon ligand 60 




































































bacterial phagocytosis and the expression of specific surface structures, co-stimulatory 62 
molecules and cytokines. Through antigen presentation and secretion of immune 63 
mediators, mature DCs (mDCs) act as messengers for the rest of the immune system, 64 
promoting differentiation of T helper (Th) cells to specific T CD4
+
 functional subsets 65 
(Hooper et al., 2012). Microbial activation of DCs towards secretion of TGF-β and IL-66 
10 promotes generation of anti-inflammatory Foxp3
+
 regulatory T cells (Treg), which 67 
are involved in immunological tolerance to gut microbiota. In contrast, secretion of IL-6 68 
and IL-1β by activated DCs predominantly induces proliferation of IL-17-secreting 69 
Th17 cells, which are crucial for the host defence response to bacterial pathogens and 70 
fungi. Th1 cells also have pro-inflammatory and protective functions against virus and 71 
bacterial pathogens. This cell subset releases INF- and TNF- and its expansion is 72 
mainly driven by DC-secreted IL-12. Secretion of IL-4 by activated DCs results in Th 73 
differentiation towards the Th2 subpopulation that secretes IL-4, IL-5, IL-13 and the 74 
anti-inflammatory IL-10. The Th2 response is predominantly activated against intestinal 75 
nematode parasites but an excessive, dysregulated Th2 propagation can promote allergic 76 
responses. Intestinal homeostasis and human health depend on well balanced Th17/Treg 77 
and Th1/Th2 responses. In this context, DCs ensure intestinal homeostasis by tuning the 78 
host immune system in response to gut microbes (Maynard et al., 2012).  79 
In addition to DC interaction with bacteria that reach the gut-associated 80 
lymphoid tissue via transcytosis across M cells, DCs also sample gut luminal content by 81 
extending pseudopodia across the epithelial cell layer (Hooper et al., 2012). Under 82 
healthy conditions, the intestinal epithelium is covered by a mucus layer that maintains 83 
segregation of microbiota and host cells. Commensal microbiota inhabits the outer 84 
mucus layer, whereas the inner mucin layer is highly compacted and prevents bacteria 85 
from gaining access to the epithelial cells (Johansson et al., 2008; Vaishnava et al., 86 
2011). Due to the gut barrier structure, microbiota-host communication is mainly 87 
mediated by secreted bacterial factors that can diffuse through the mucus layer and 88 
interact with cells of the intestinal mucosa. Besides metabolites and soluble secreted 89 
proteins, bacteria also release active mediators through extracellular membrane vesicles 90 
(MVs).  91 
There is growing body of evidence that microbiota-derived MVs are key players 92 
in inter-kingdom communication as mediators of the effects of gut resident bacteria on 93 
host immune and defence responses (Kaparakis-Liaskos & Ferrero, 2015). In this 94 




































































bacterial species is a normal constituent of the gut microbiota. Certain intestinal E. coli 96 
isolates such as the strain Nissle 1917 (EcN) (Nissle, 1916; Sonnenborn & Schulze, 97 
2009) have probiotic properties while others are considered commensal strains although 98 
they have pathogen-like genes. The human gut is a reservoir of these pathobionts, which 99 
mainly fit in the E. coli phylogenetic group B2 that comprises strains that cause extra-100 
intestinal infections. Although it is a safe probiotic, EcN belongs to the phylogenetic 101 
group B2 (STEC Center, http://www.shigatox.net/new/reference-strains/ ecor.html) and 102 
shares a common ancestor with uropathogenic E. coli strains. During evolution, EcN 103 
lost virulence factors but conserved genes encoding fitness factors that contribute to its 104 
competitiveness and survival in the densely populated human gut (Vejborg et al., 2010; 105 
Toloza et al., 2015). This probiotic interferes with enteric pathogens and displays anti-106 
inflammatory and barrier strengthening activities. The immunomodulatory properties of 107 
EcN have been associated with the synthesis of colibactin (Olier et al., 2012) and the 108 
expression of a K5 capsule, which in addition mediates interactions with intestinal 109 
epithelial cells (Hafez et al., 2009; Hafez et al., 2010, Hafez, 2012).  110 
The effects of microbiota MVs depend on their bacterial origin and cargo. 111 
Consequently, some of them are strain specific. For instance, MVs released by the gut 112 
symbiont Bacteroides fragilis induce Treg cells and mucosal tolerance through the 113 
delivery of the immunomodulatory polysaccharide A (Shen et al., 2012). Our studies 114 
showed that MVs isolated from the probiotic EcN (group B2) and the commensal 115 
ECOR12 (group A) and ECOR63 (group B2) are internalized by intestinal epithelial 116 
cells via clathrin-mediated endocytosis (Cañas et al., 2016) and modulate host immune 117 
and defence responses. In intestinal epithelial cells, internalized MVs activate NOD1-118 
dependent signalling pathways and contribute to microbiota-driven basal inflammation 119 
(Cañas et al., 2018). In addition, MVs from EcN and ECOR12 exhibit 120 
immunomodulatory effects on human colonic explants and in cellular models that 121 
mimic the intestinal epithelial barrier. In fact, these vesicles activate the synthesis of 122 
antimicrobial peptides and modulate the expression of inflammatory mediators towards 123 
an anti-inflammatory profile (Fábrega et al., 2016). Concerning barrier protection 124 
effects, MVs from EcN and ECOR63 reinforce the intestinal epithelial barrier and 125 
reduce gut permeability by modulating the tight junction proteins ZO-1, claudin-14 and 126 
claudin-2 (Alvarez et al., 2016). The anti-inflammatory and barrier strengthening 127 




































































administration of MVs isolated from this probiotic ameliorate inflammation and colitis 129 
progression in dextran sodium sulphate-treated mice (Fábrega et al., 2017).  130 
The aim of this study was to evaluate the ability of MVs released by probiotic 131 
and commensal E. coli strains that belong to different phylogenetic groups to modulate 132 
DC function in vitro. We selected from the E. coli reference collection ECOR strain 133 
ECOR12 (group A) and strains ECOR63 and ECOR53 (group B2). Unlike ECOR63, 134 
strain ECOR53 expresses functional haemolysin and causes cytotoxicity in the murine 135 
macrophage cell line J774 (Lai et al., 1999). MVs isolated from an EcN K5-deficient 136 
mutant were also analysed to test whether the K5 capsular polysaccharide mediates EcN 137 
immunomodulatory effects in DCs. The vesicle-modulating properties were analysed in 138 
monocyte-derived DCs (mo-DCs) by measuring the cytokine release profile and the 139 
ability of induced-DCs to differentially modulate activation of CD4
+
 T cells towards 140 
Treg, Th17 and Th1 effector responses.  141 
 142 
2. Materials and methods 143 
 144 
2.1.  Bacterial Strains and Growth Conditions 145 
The probiotic strain EcN (serotype O6:K5:H1) was provided by Ardeypharm 146 
(GmbH, Herdecke, Germany). The EcN knockout mutant lacking the K5 capsule 147 
(EcN:K5) was kindly provided by I. Roberts. This mutant was generated by 148 
replacement of the kfiC gene with a chloramphenicol resistance cassette (Hafez et al., 149 
2009). ECOR12, ECOR63 and ECOR53 are E. coli strains from the ECOR reference 150 
collection that were isolated from stool samples of healthy human donors (Ochman & 151 
Selander, 1984). Bacterial strains were grown in Luria-Bertani broth (LB) at 37°C, with 152 
constant rotation (150 rpm). The EcN:K5 mutant strain was routinely grown on LB-153 
chloramphenicol, except for MV isolation. In that case, the culture medium was 154 
antibiotic-free LB to maintain equal growth conditions for all strains. Growth was 155 
monitored by measuring the optical density at 600 nm. 156 
 157 
2.2. Isolation of MVs and Cryo-TEM analysis 158 
MVs were isolated from culture supernatants as described previously (Aguilera 159 
et al., 2014). Briefly, E. coli strains were grown overnight in LB and the culture was 160 




































































then filtered through a 0.22 μm-pore-size filter (Merck Millipore, Massachusetts, USA) 162 
and concentrated by centrifugation in a Centricon Plus-70 filter device (Merck 163 
Millipore, Massachusetts, USA). After an additional filtration step, vesicles were 164 
collected by centrifugation at 150,000 × g for 1 h at 4°C, washed and resuspended in 165 
PBS. Quantification of MV samples was assessed by protein concentration and sterility 166 
was confirmed on LB plates. Aliquots of MVs were stored at -20°C until use. 167 
Cryo-transmission electron microscopy (Cryo-TEM) analysis was performed 168 
with fresh MVs samples resuspended in 0.1 M phosphate buffer (pH 7.2) as described 169 
previously (Perez-Cruz et al., 2016). Briefly, one drop of each MV suspension (5 μl) 170 
was applied on the carbon surface of a glow-discharged Lacey Carbon 300 mesh copper 171 
grid (Ted Pella, USA). The sample was allowing to adsorb for 4 min at 100% humidity 172 
inside the chamber of the Vitrobot Mark III (FEI Company, Eindhoven, Netherlands). 173 
The excess of liquid was automatically blotted with filter paper, followed by cryo-174 
immobilization by plunge freezing in liquefied ethane. The vitrified sample was stored 175 
in liquid nitrogen until its observation in the cryo-electron microscope. Plunge-frozen 176 
sample was transferred to a Tecnai F20 EM (FEI, Eindhoven, The Netherlands) using a 177 
cryo-holder system (Gatan, Pleasanton, USA). The sample was examined at 200 kV, at 178 
a temperature ranging from −179 to −170°C, using low-dose imaging conditions. Low-179 
dose images were recorded with a 4096 × 4096-pixel CCD Eagle camera (FEI, 180 
Eindhoven, The Netherlands). 181 
 182 
2.3. Generation of human monocyte-derived DCs 183 
Human mo-DCs were generated in vitro as described elsewhere (Lopez et al., 184 
2012). Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from fresh 185 
buffy coats of healthy donors, provided by the “Banc de Sang i Teixits” of Barcelona 186 
according to the signed agreement with the Institution. Use of anonymous, non-187 
identifiable human samples was approved by the Bioethics Committee of the University 188 
of Barcelona (Institutional Review Board:1R800003099). Human PBMCs were isolated 189 
by density gradient centrifugation using Histopaque 1077 (Sigma-Aldrich Chemical Co, 190 
St. Louis, USA) following the manufacturer’s instructions. Monocytes were isolated 191 
from PBMCs by positive selection using magnetic-activated cell sorting with CD14 192 
microbeads (Miltenyi Biotec, Bergish Gladbach, Germany) and cultured at density 2 x 193 
10
5




































































differentiation medium that contains 800 IU/ml GM-CSF and 1000 IU/ml IL-4 195 
(Miltenyi Biotec, Bergish Gladbach, Germany). Fresh complete MO-DC medium 196 
containing GM-CSF and IL-4 was added the fourth day of culture. 197 
 198 
2.4. Mo-DCs stimulation and maturation  199 
On day 6, immature mo-DCs (iDCs) were washed and kept in fresh MO-DC 200 
differentiation medium for at least one hour at 37ºC in 5% CO2 before the addition of 201 
MVs (10  g/ml).  After 24-hour incubation with MVs at 37ºC in 5% CO2, maturation of 202 
dendritic cells was verified by flow cytometry analysis of surface maturation markers. 203 
DC supernatants were sterile filtered through a 0.2 µm pore filter and stored at -80ºC for 204 
cytokine quantification. 205 
  206 
2.5.  Isolation of CD4+ T cells from PBMCs and DCs/CD4+ T cells co-culture  207 
CD4
+
 T cells were isolated from human PBMCs by positive selection using 208 
MACS CD4
+ 
T Cell Isolation Kit (Miltenyi Biotec, Bergish Gladbach, Germany) and 209 
resuspended in fresh complete TexMACs
 TM
 media (Miltenyi Biotec, Bergish Gladbach, 210 




 T cell purity was greater than 95%. 211 
Then, DCs stimulated for 24 h with MVs (mature DCs, mDCs) were washed and co-212 
cultured with isolated allogenic CD4
+
 T cells in 12-well plates at a DC:T cell ratio of 213 
1:5 (2× 10
5
 DCs / 1 x 10
6
 T cells) in TexMACs medium (Höpken et al. 2005). Single 214 
cultures of CD4
+
 T cells and iDC/CD4
+
 T cell co-cultures were processed in parallel as 215 
a control. After 3 days incubation, culture supernatants were collected, centrifuged and 216 
filtered for cytokine quantification, and pelleted lymphocytes were stained for flow 217 
cytometry analysis of Th17 (CD196
+
) and Treg (CD25(high), FoxP3
+
) phenotypes.  218 
 219 
2.6. Stimulation of mo-DCs across Caco-2 cell monolayers   220 
The intestinal epithelial cell line Caco-2 (ATCC HTB37) was routinely cultured 221 
in DMEM High Glucose supplemented with 10% foetal bovine serum (FBS), 25 mM 222 





) were seeded on the apical surface of polycarbonate 224 
Transwell filter inserts (12 mm, 0.4-μm-pores; Millipore, Massachusetts, USA) and 225 
cultured for 15-18 days with medium changes on alternate days. Monolayer integrity 226 




































































as previously reported (Alvarez et al. 2016). Activation of Caco-2 monolayers with 228 
MVs was performed at TER values greater than 800 Ω.cm2. After PBS washing, Caco-229 
2 monolayers were kept in fresh medium, and apically stimulated with MVs (10 μg/ml) 230 
for 24 h. Some wells were left untreated as a control. Culture supernatants were then 231 
collected from the basolateral compartments and used to activate mo-DCs (1 × 10
6 
232 
cells/ml). After 24 h incubation, the DC culture supernatant was collected for 233 
quantification of secreted cytokines.  234 
 235 
2.7. Flow Cytometry 236 
Maturation of vesicle-stimulated mo-DCs was verified by flow cytometry using 237 
the MO-DC Differentiation Inspector Kit (Miltenyi Biotec, Bergish Gladbach, 238 
Germany). Briefly, cells were centrifuged (200 x g, 5 min) and stained for 15 min at 4ºC 239 
with monoclonal antibody (mAb) anti-CD14 fluorescein isothiocyanate (FITC) (clone 240 
Tuk4), anti-CD209 R-phycoerythrin (PE) (clone DCN-47.5.4) and anti-CD83 241 
allophycocyanin (APC) (clone HB15) following the manufacturer’s protocol. A human 242 
control cocktail of isotype matched conjugated irrelevant mAbs was used as a negative 243 
control. Cells were resuspended in PBS 2% BSA and kept on ice until flow cytometric 244 
analysis. Stained cells (at least 10,000 events) were acquired on a Gallios flow 245 
cytometer (Beckman Coulter, Inc, Fullerton, CA, USA) with a 3-laser-10 colour 246 
standard configuration.  247 
After 3 days co-incubation of vesicle-stimulated mo-DCs with CD4
+
 T cells, 248 
lymphocytes were collected, washed and resuspended in PBS 2% BSA for Th17 and 249 
Treg phenotypic analysis. For surface marker staining, lymphocytes were first stained 250 
with anti-CD4 FITC (clone VIT4), anti-CD25 APC (clone 4E3) and anti-CD196 PE 251 
(clone REA190) mAb or with the corresponding isotype-matched conjugated irrelevant 252 
antibody (Miltenyi Biotec, Bergish Gladbach, Germany). Then, cells were fixed, 253 
permeabilized and intracellularly stained with anti-FoxP3 PE (clone 3G3) (Miltenyi 254 
Biotec, Bergish Gladbach, Germany) or with the corresponding isotype-matched 255 
control, following the manufacturer’s instructions. A minimum of 10,000 stained CD4
+
 256 
lymphocytes were acquired on a Gallios flow cytometer. The specific fluorescence 257 
intensity was quantified as the mean fluorescence intensity (MFI) calculated by 258 
subtracting the background of isotype matched control staining from the total 259 







































































2.8.  Cell Viability assays  264 
Cell viability was assessed by flow cytometry using the exclusion dye 4′,6-265 
diamidino-2-phenylindole (DAPI) violet. In addition, the trypan blue exclusion test and 266 
the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay were 267 
used to evaluate cell viability in vesicle-stimulated DCs. For this, 1x10
5
 mo-DCs in 100 268 
μl of media were plated into each well in a 96-well plate and incubated for 24 h at 37°C 269 
before the addition of MVs (10 μg/ml). After 24 h-incubation, cells were treated with 270 
0.25% MTT (Sigma-Aldrich Chemical Co, St. Louis, MO, USA) in PBS and allowed to 271 
react for 2 h at 37°C. The medium was then removed and 0.1 ml of solubilization 272 
reagent (99% dimethyl sulfoxide) was added. Cell viability was measured at 570 nm in 273 
a Modulus™ Microplate Photometer (Turner BioSystems Inc., Sunnyvale, CA, USA). 274 
The results were expressed as percentage of cell survival relative to the control 275 
(untreated mo-DCs). 276 
 277 
2.9.  RNA isolation and quantitative reverse transcription-PCR (RT-qPCR) 278 
Total RNA was extracted from mo-DCs using a Qiagen RNeasy Mini Kit 279 
according to the manufacturer’s instructions (Qiagen, Crawley, UK). RNA quality and 280 
concentration were assessed by the ratio of absorbance at 260 and 280 nm using a 281 
NanoDrop TM-2000 spectrophotometer (Thermo Fisher Scientific, Waltham, 282 
Massachusetts, USA). RNA integrity was verified by visualization of 28S and 18S 283 
rRNAs after 1% agarose/formaldehyde gel electrophoresis. 284 
For RT-qPCR, 1 µg RNA was reverse transcribed using the High Capacity 285 
cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA) in a final 286 
volume of 20 µl. Quantitative PCR reactions were performed in a StepOne Plus PCR 287 
cycler (Applied Biosystems, Foster City, CA, USA) by using SYBR® Green PCR 288 
Master Mix (Applied Biosystems, Foster City, CA, USA) and specific oligonucleotides 289 
for IL-6, TNF-α, IL-10 and TGF-β (Table 1). The housekeeping HPRT-1 gene was used 290 
as a normalizing gene. A control reaction was performed in the absence of RNA. The 291 
standard PCR program was: one denaturation cycle for 10 min at 95ºC followed by 40 292 




































































fold change compared with control and calculated by means of 2
-ΔΔCt
 formula (Livak & 294 
Schmittgen, 2001). 295 
 296 
2.10.  Cytokine quantification 297 
Secreted cytokines, IFNγ, IL-1β, TNF-α, IL-12p70, IL-17A, IL-18, IL-22, IL-23, 298 
IL-4, IL-5, IL-13, IL-10, and TGF-β were quantified in culture supernatants by the 299 
human ProcartaPlex Multiplex Immunoassay (eBiosciences Inc., San Diego, CA, USA) 300 
according to manufacturer's instructions. Concentration of each analyte was detected 301 
using the MAGPIX instrument (Luminex Corp., Austin, TX, USA) in the facilities of 302 
the Scientific and Technological Centres of the University of Barcelona (CCiT-UB), 303 
and results were analysed with xPONENT
®
 4.2 software (Luminex Corp., Austin, TX, 304 
USA). The results were expressed as pg/ml. 305 
 306 
2.11. Statistical Analysis 307 
Statistical analysis was performed using GraphPad Prism 7.0 software (GraphPad, 308 
San Diego, CA, USA) and data were expressed as mean ± standard error of the mean 309 
(SEM). Data are at least from three independent biological experiments. Three 310 
separated wells were processed for each independent experiment. To establish the 311 
distribution of the data, the test Shapiro Wilk was run. To assess the effect of every 312 
experimental condition compared to the other conditions, one-way ANOVA followed 313 
by Bonferroni’s test (normal distribution) or the Kruskal-Wallis followed by Dunn’s test 314 
(non-normal distribution) were performed. Significant differences were established at p-315 
value ≤ 0.05.  316 
 317 
3. Results 318 
3.1. Isolation and characterization of MVs produced by gut resident E. coli strains 319 
Previous studies by our group evidenced that MVs released by the probiotic EcN 320 
and the commensals ECOR63 and ECOR12 modulate in a strain-specific manner the 321 
expression of cytokines and tight junction proteins in intestinal epithelial cells (Fábrega 322 
et al., 2016; Alvarez et al., 2016; Cañas et al., 2018). To prove that secreted 323 
extracellular MVs are also a mechanism used by gut resident strains to specifically 324 




































































of the probiotic EcN and the intestinal isolates ECOR63, ECOR53 and ECOR12. MVs 326 
from an EcN isogenic mutant unable to synthesise polysaccharide K5 were also purified 327 
to assess capsule-mediated effects on DCs. To evaluate strain-specific changes in 328 
vesicle size or structure, isolated MVs were examined by cryo-TEM (Fig. 1). As 329 
described for EcN vesicles (Pérez-Cruz et al., 2016), MVs from all E. coli strains had a 330 
spherical shape and a size between 20 and 200 nm. Although size distribution varied 331 
according to the producer strain, most were in the range of 20 - 80 nm, except for 332 
EcN:K5 that were enriched in MVs ranging from 80 to 110 nm. In addition to the larger 333 
size, the bilayer surface of MVs from the K5 capsule-deficient mutant (EcN:K5) was 334 
thicker than that of the wild-type EcN vesicles. In all samples, common Gram-negative 335 
single-bilayer outer membrane vesicles predominated in all observed fields, but double-336 
bilayer vesicles, named outer-inner membrane vesicles (Pérez-Cruz et al., 2015), were 337 
also observed occasionally (Fig. 1). 338 
  339 
3.2. MVs from gut resident E. coli strains elicit distinct pattern of cytokine secretion in 340 
stimulated human mo-DCs  341 
Considering that bacterial MVs serve as vehicles for cell-to-cell communication 342 
in the gut and that their effects are strain specific, we evaluated the ability of MVs 343 
isolated from gut resident E. coli strains to induce maturation of DCs in vitro. Human 344 
mo-DCs were exposed to MVs of each strain for 24 h. In all assays, cell viability values 345 
above 95% were confirmed by flow cytometry analysis of both control and stimulated 346 
mo-DCs. In addition, viable cells were estimated by the MTT and trypan blue exclusion 347 
assays. Results showed no significant differences in MTT reduction levels between 348 
control and MV-treated mo-DCs (Figure S1).  349 
Maturation of mo-DCs was assessed by flow cytometry analysis using the MO-350 
DC differentiation inspector kit (Miltenyi Biotec). All MVs regardless of their origin 351 
induced high levels of the maturation surface marker CD83 compared to untreated mo-352 
DCs, which confirms DC maturation. Consistently, vesicle-stimulated DCs showed 353 
reduced expression of CD209 (DC-SING) whereas CD14 expression remained low 354 
(Fig. 2).  355 
Stimulation of mo-DCs with bacterial MVs also activated expression of 356 
cytokines to initiate specific immune responses. Cell culture supernatants from treated 357 




































































related or to prime Th responses, namely INF-, IL-12 and IL-18 (Th1-related); IL-6, 359 
IL-23, TNF- and IL-1β (Th17/Th22), and IL-10 and TGF-β (Treg). In comparison 360 
with non-treated mo-DCs, MVs from all strains induced statistically significant 361 
secretion of all the cytokines assayed, although the observed profile differed greatly 362 
between strains (Fig. 3). MVs from the non-pathogenic E. coli B2 strains EcN 363 
(probiotic) and ECOR63 (commensal) elicited greater secretion of Th1 polarizing 364 
cytokines than MVs from ECOR12 MVs (group A) or the pathogenic ECOR53 (Fig. 3, 365 
panels A-C). In contrast, the highest expression levels of Treg-related cytokines, IL-10 366 
and TGF-β, were achieved by treatment with ECOR12 MVs (Fig. 3, panels H,I). 367 
Vesicles from the probiotic EcN tend to induce greater secretion of Treg cytokines than 368 
MVs from other B2 strains although differences did not reach statistical significance 369 
(Fig. 3, panels H,I). All MVs enhanced secretion of Th17/Th22 priming cytokines, 370 
without significant differences between strains (Fig. 3, panels D-G). Considering K5-371 
mediated effects, the results showed that the cytokine secretion pattern elicited by 372 
EcN:K5 MVs only differed significantly from that of wild-type EcN MVs in the Th1-373 
driving cytokines, specifically INF-, IL-12 and IL-18 (Fig. 3, panels A-C). 374 
Gene expression of cytokines commonly used as markers of DC activation was 375 
analysed by RT-qPCR at 6 h stimulation with MVs (Fig. 4). Results revealed higher 376 
mRNA levels for IL-6, TNF-α, IL-10 and TGF-β in stimulated DCs than in controls, 377 
regardless of the vesicle origin, except for TGF-β expression (Fig. 4, panels A-C). The 378 
mRNA levels of TGF-β in DCs incubated with ECOR53 MVs did not differ from 379 
control DCs (Fig. 4D). For each type of MVs, the mRNA expression profile was quite 380 
similar to that of the corresponding values of secreted cytokines (Fig. 3).  381 
 382 
3.3. The T cell responses triggered by MV-stimulated mo-DCs are strain specific 383 
We next evaluated the ability of MVs to induce DC modulation of T cell 384 
function and phenotype using vesicle-stimulated DCs/CD4
+
 T cell in vitro co-cultures. 385 
As a control CD4
+
 T cells were co-incubated with non-treated DCs. After 3 days, 386 
secreted levels of IFN-, IL-17, IL-22, IL-4, IL-5, IL-13, IL-10 and TGF-β were 387 
quantified (Fig. 5). DCs exposed to MVs isolated from gut beneficial bacteria induced 388 
higher levels of all cytokines than unstimulated DCs (Fig. 5, panels A-H), whereas DCs 389 
challenged with ECOR53 MVs failed to induce IL-10 and TGF-β over control values 390 




































































similar levels (Fig. 5, panels D-F). A comparison of commensal and probiotic strains 392 
revealed that ECOR12 MVs, a commensal that belongs to the phylogenetic group A, 393 
triggered robust secretion of TGF-β (Fig. 5H) and lower expression of the inflammatory 394 
cytokines INF- (Th1 response) and IL-17 (Th17 response) than MVs from probiotic 395 
EcN and other E. coli B2 strains (Fig. 5, panels A,B). No differences in the effects on 396 
IL-22 secretion were observed between stimulated DCs, except for DCs exposed to 397 
ECOR53 MVs that triggered significantly lower secreted IL-22 (Fig. 5C). A similar 398 
pattern was observed for IL-10 secretion, although secreted values tended to be higher 399 
in co-cultures containing DCs stimulated with EcN and ECOR12 MVs (Fig. 5G). The 400 
ratio of TGF-β/IL-17 revealed that cell responses induced by ECOR12 MVs are 401 
predominantly directed towards TGF-β secreting Treg cells, whereas probiotic EcN 402 
induced compensated Treg/Th17 responses (Fig. 5I). The Th1 response was mainly 403 
driven by E. coli strains belonging to group B2. Cytokine results were supported by 404 
quantification of the Treg and Th17 subsets by cellular immunostaining for selective 405 
markers after a 3-day co-incubation, specifically CD4/CD25 high/Foxp3 for Treg and 406 
CD4/CD196 for Th17 (Fig. 6).  Again, values of the Treg/Th17 ratio confirmed the 407 
predominant Treg response induced by ECOR12 MVs. In the case of MVs from the 408 
probiotic EcN, the results supported a balanced Treg/Th17 response, which was not 409 
significantly affected by K5 deficiency. This analysis also showed that MVs of non-410 
probiotic B2 strains (ECOR63 and ECOR53) elicited lower Treg responses than EcN 411 
MVs, although the differences did not reach statistical significance. 412 
 413 
3.4. Effect of the epithelial layer on vesicle-mediated activation of immature 414 
DCs 415 
Since in the gut DCs are in close contact and communicate with epithelial cells we 416 
sought to examine the potential of MVs to indirectly stimulate DCs through the 417 
intestinal epithelium layer. To this end, mo-DCs were incubated with supernatants 418 
collected from the basolateral compartment of Caco-2 polarized monolayers exposed for 419 
24 h to MVs from the probiotic EcN and the commensal ECOR63 and ECOR12 strains. 420 
Incubation of DCs with unstimulated Caco-2 conditioned medium was also performed 421 
as a control of the basal epithelial – dendritic cell crosstalk. IL-10, TNF-α and IL-6 were 422 
quantified after 24 h incubation of DCs with conditioned Caco-2 supernatants (Fig. 7A-423 




































































measured in the collected supernatants before being used for DC stimulation (Fig. 7, 425 
panels A-C, black bars). In the absence of vesicle-stimulation, Caco-2 conditioned 426 
supernatants triggered secretion of TNF-α and IL-10 by immature mo-DCs (Fig. 7, 427 
panels B-C, white bars) a finding compatible with the communication between 428 
epithelial and immune cells by means of epithelial released factors. A two-fold increase 429 
in the secreted values of both cytokines was observed in mo-DCs incubated with 430 
supernatants from vesicle-exposed Caco-2 cell monolayers (Fig. 7, panels B-C, white 431 
bars). In contrast, secretion of IL-6 by conditioned DCs was only detected when these 432 
immune cells had been incubated with vesicle-exposed Caco-2 supernatants (Fig. 7, 433 
panel A). In this undirect model of DC activation, cytokine values were substantially 434 
lower than those secreted by direct vesicle-stimulated DCs (Fig. 3, panels D, G, H).  435 
 436 
Discussion 437 
The probiotic EcN is the single active component of Mutaflor
®
, a probiotic formula 438 
with proven effectiveness in the treatment of acute diarrhoea (Henker et al., 2007) and 439 
inflammatory intestinal disorders such as ulcerative colitis (Kruis et al., 2004; Kruis et 440 
al., 2012; Chibbar & Dieleman, 2015). It has been widely reported that EcN positively 441 
modulates intestinal homeostasis and microbiota balance through several mechanisms 442 
that include: (i) modulation of the host immune response towards an anti-inflammatory 443 
balance (Trebichavsky et al., 2010), reinforcement of the intestinal epithelial barrier by 444 
strengthening tight junctions between intestinal epithelial cells (Ukena et al., 2007; 445 
Zyrek et al., 2007; Hering et al., 2014) and upregulation of antimicrobial factors such as 446 
microcins and β-defensin-2 (Schlee et al., 2007; Sassone-Corsi et al., 2016). This 447 
probiotic is in fact a gut beneficial bacterium that was originally isolated from a soldier 448 
who survived a severe outbreak of diarrhoea during the First World War. Like other 449 
components of the gut microbiota, probiotics use a wide range of signals to modulate 450 
the intestinal immune function. Due to the huge microbial population that inhabit the 451 
intestinal tract, host barrier and regulatory mechanisms are required to control bacteria-452 
host reciprocal interactions, aimed at preventing aberrant responses and ensuring 453 
homeostasis. The first intestinal barrier that prevents direct contact between gut 454 
microbes and epithelial and immune cells is the mucus layer that covers the intestinal 455 
epithelium. Thus, gut microbiota-host crosstalk is mainly accomplished by secreted 456 




































































extracellular vesicles are considered key players in bacteria-host communication, as 458 
they permit delivery of bacterial effectors into host cells without direct intercellular 459 
contact. MVs secreted by Gram-negative bacteria enclose a wide range of cargos, 460 
including numerous MAMPs such as LPS, lipoproteins, peptidoglycan, DNA and RNA 461 
that can engage host PRRs to initiate signalling cascades. Upon interaction with host 462 
epithelial or immune cells, bacterial MVs are internalized by endocytosis and 463 
intracellularly deliver the active compounds that elicit suitable responses (Kaparakis-464 
Liaskos & Ferrero, 2015).  465 
Due to the importance of bacterial MVs in intercellular dialogue, research in this 466 
field was first focused on pathogen-derived MVs and infection diseases. Nowadays, the 467 
study of MVs secreted by gut microbiota and probiotics is an emerging topic (Molin-468 
Tijeras et al., 2019). Our group was pioneer in the study of probiotic MVs, specifically 469 
vesicles from the Gram-negative probiotic EcN. We focused on the proteomic 470 
characterization of EcN MVs and their immunomodulatory and barrier protective 471 
effects in intestinal epithelial cells (Aguilera et al., 2014; Fábrega et al., 2016; Alvarez 472 
et al., 2016; Cañas et al., 2018). We also reported that EcN MVs reduce inflammatory 473 
scores in a DSS-induced experimental colitis model in mice (Fábrega et al., 2017). 474 
Comparative studies revealed that MVs released by other intestinal E. coli also display 475 
some beneficial effects. Particularly, ECOR63 MVs reinforce tight junctions in 476 
intestinal cell monolayers (Alvarez et al., 2016) whereas ECOR12 lacks this activity but 477 
elicits immunomodulatory effects in intestinal epithelial cells and colonic explants 478 
(Fábrega et al., 2016; Cañas et al., 2018).   479 
Here we have expanded our study to the effects mediated by MVs on DCs 480 
function, including vesicles from the probiotic EcN and from commensal E. coli strains 481 
isolated from faecal microbiota of healthy individuals and representing distinct 482 
populations. We showed that all the MVs that were analysed elicited maturation of mo-483 
DCs but with distinct activation profile. No significant differences were observed in the 484 
expression of the general maturation marker CD83 between strains, whereas secreted 485 
levels of Treg and Th1-driving cytokines differed greatly, depending on the vesicle 486 
producer strain. The inflammatory Th1 response is crucial to fight against pathogens 487 
and resolve infection. In contrast, regulatory T cells are critical for sustained immune 488 
tolerance in the intestine. MVs from the B2 strains EcN and ECOR63, elicited higher 489 




































































well-known that INF- and IL-12 have potent effects on T cell differentiation into Th1 491 
cells. Although IL-18 cannot induce Th1 cell development per se, it is considered a 492 
proinflammatory cytokine that potentiates type 1 responses by activating established 493 
Th1 cells to secrete IFN-γ in the presence of IL-12 (Nakanishi, 2018). Therefore, 494 
activation of iDCs to secrete Th1 driving cytokines by EcN MVs may be one of the 495 
mechanisms exploited by this probiotic to protect against viral and bacterial enteric 496 
infections. This effect could be mediated, at least in part, by the K5 capsular 497 
polysaccharide. A similar EcN activation profile of Th1-driving cytokines was triggered 498 
by MVs from other intestinal B2 strains with beneficial traits such as ECOR63. 499 
Although it belongs to the same B2 group, ECOR53 MVs triggered significantly 500 
reduced activation of INF-, IL-12 and IL-18. This difference may be associated with 501 
the potential pathogenic trait of ECOR53. The phylogenetic group B2 mainly encloses 502 
virulent strains that cause extra-intestinal infections. In fact, strain ECOR53, but not 503 
ECOR63, expresses functional haemolysin and produces strong cytotoxicity in 504 
macrophages (Lai et al., 1999). It is widely described that pathogenic bacteria have 505 
evolved multiple strategies to bypass the host cellular machinery and immune responses 506 
to ensure survival. One strategy is modulation of the host inflammatory response by 507 
expressing bacterial anti-inflammatory proteins that avoid pathogen clearance and help 508 
bacteria to persist in the host cells. Most of these proteins are adhesins or surface 509 
proteins, and hence could be enclosed in MVs (Sun, 2010). Our results suggest that an 510 
ECOR53 factor or protein that can modulate DC function towards a reduced Th1 511 
response is secreted and delivered through MVs. Concerning secretion of Treg 512 
polarizing cytokines, IL-10 and specifically TGF-β, the results were clearly different. 513 
The highest activation was achieved by incubation with MVs isolated from ECOR12. 514 
The E. coli phylogenetic group A is predominant in human stool isolates and principally 515 
comprises commensal strains that lack virulence determinants. Thus, these “innocuous” 516 
E. coli strains may help to maintain gut homeostasis by enhancing innate immunity and 517 
controlling the Treg/Th17 balance towards an anti-inflammatory profile. Interestingly, 518 
EcN MVs elicited higher activation of TGF-β and IL-10 secretion than other B2 strains, 519 
a fact that is consistent with the probiotic trait of this strain. Collectively, these data 520 
indicate that the probiotic EcN modulated DCs towards better balanced Treg/Th17 521 
responses than non-probiotic B2 strains. Regarding the expression of Th17 and Th22-522 
driving cytokines (IL-6, IL1-β, IL-23 and TNF-α) (Eyerich et al., 2017), our results 523 




































































differences between the non-pathogenic E. coli strains. However, secreted levels of IL-525 
23 (Th17 expansion) and TNF-α (Th22-differentiation) were significantly lower in DCs 526 
stimulated with ECOR53 MVs. Th17 and Th22 cell lineages share some functional 527 
features but the corresponding secreted cytokines specifically differ in some activities. 528 
IL-17 is mostly a pro-inflammatory cytokine involved in protection against extracellular 529 
bacterial infections, whereas IL-22 has high potential to protect tissue integrity and help 530 
tissue regeneration (Eyerich et al., 2017). 531 
Subsequent co-incubation of vesicle-stimulated DCs and allogenic CD4
+
 T cells 532 
proved the ability of activated DCs to drive complex Th responses that were consistent 533 
with their secreted cytokine profile. MVs from all strains analysed triggered similar Th2 534 
responses.  Except for ECOR53, all MVs activated IL-10 secreting T cells and 535 
promoted a strong Th22 response. In addition, MVs from the probiotic EcN induced an 536 
intricate response involving INF- secreting Th1 cells, IL-17 secreting Th17 cells and 537 
TGF-β secreting FoxP3
+ 
Treg cells. A similar response was activated by ECOR63 MVs. 538 
Nonetheless, levels of secreted pro-inflammatory INF- were higher than those induced 539 
by EcN MVs and IL-10 and TGF-β levels tended to be lower. Consistently, values of 540 
the IL-10/INF- ratio revealed that the Th response induced by ECOR63 MVs has a 541 
stronger pro-inflammatory profile than those driven by EcN or ECOR12 MV. No 542 
significant differences were observed in the Th response triggered by DCs stimulated 543 
with EcN K5-deficient MVs versus wild-type EcN MVs except for the significantly 544 
lower secretion of IFN-. These data correlate with the profile of DCs stimulated with 545 
these MVs and point to K5 capsule as a modulator factor of Th1-related cytokines. 546 
Concerning strain ECOR12, the MVs also induced a combined Th1-Th2-Th17-Th22-547 
Treg response, but the overall outcome is dominated by high levels of TGF-β, the 548 
unique cytokine secreted by Treg cells. In this case, levels of Th1 and Th17-secreted 549 
cytokines were lower than those elicited by EcN MVs. Flow cytometry analysis of Th17 550 
and Treg markers confirmed the T cell subset profile induced by the different MVs: (i) a 551 




) induced by non-552 
pathogenic MVs and a reduced proportion in the case of ECOR53 MVs, and (ii) 553 
ECOR12 promoted the highest increase in the Foxp3
+
 Treg population, followed 554 
sequentially by EcN and ECOR63. MVs from ECOR53 failed to increase this T cell 555 




































































As stated above, DCs preserve intestinal homeostasis by tuning the host immune 557 
system in response to gut microbes. However, in the normal gut very few bacteria can 558 
cross the inner mucin layer to reach DCs associated with the intestinal epithelium. In the 559 
present study, we have shown that the immune modulating properties of the probiotic 560 
EcN and commensal strains are mediated by secreted extracellular vesicles, which can 561 
go through the mucin layer (Cañas et al. 2016) and be easily sensed by M cells or 562 
phagocyted by DCs. Microbiota-derived vesicles also interact with the intestinal 563 
epithelium and modulate its functions. As stated above, previous studies of our group 564 
proved that microbiota vesicles are internalized in intestinal epithelial cells and 565 
modulate the immune and defence responses in a strain-specific manner. The intestinal 566 
epithelium layer is a key regulator of barrier function and immune homeostasis. Among 567 
the diverse functions, intestinal epithelial cells sense the gut microbial population, 568 
respond to microbial stimuli and coordinate appropriate immune responses. It has been 569 
shown that, upon contact with bacteria, intestinal epithelial cells release mediators that 570 
modulate immune cells in the lamina propria, favouring a tolerant and permissive 571 
environment for colonization by commensal bacteria (reviewed in Peterson & Artis, 572 
2014). Many studies in this field have been performed by incubating intestinal epithelial 573 
cells with bacterial suspensions. Here we have shown that intestinal epithelial 574 
monolayers exposed to MVs from intestinal E. coli strains can integrate and transmit 575 
signals to DCs. Activation of DCs through the epithelial barrier resulted in lower 576 
secretion of IL-6, TNF-α and IL-10 than direct activation by MVs, thus suggesting that 577 
microbiota-derived MVs modulate the epithelial-dendritic cell crosstalk and contribute 578 
to DC training towards low responsiveness against commensal bacteria. 579 
Due to the health-promoting capacities of probiotics, their inclusion in processed 580 
foods and potential clinical applications are receiving considerable attention in our 581 
society. Nonetheless, the translation of probiotics or microbiota-based treatments to 582 
human health depends on basic knowledge of the molecular mechanisms involved in 583 
their interaction with the host. It should also be considered that live probiotics may have 584 
putative adverse effects or cause invasive infections in immunocompromised patients. 585 
In this context, probiotic-derived MVs could be explored as a new and safe (bacteria-586 






































































Gut beneficial microbes modulate the innate immune system and preserve intestinal 590 
homeostasis by facilitating quick responses against pathogens and ensuring tolerance to 591 
symbiont bacteria. Here we provide evidence that MVs represent a mechanism used by 592 
probiotics and commensal strains to steadily prime the innate immune system, 593 
activating DCs in a strain-specific manner. MVs from the probiotic EcN drive complex 594 
Th responses: Th2 (repair response against tissue damaging nematodes), Th22 (tissue 595 
protection), Th1 (pro-inflammatory, protective immunity to pathogens), Th17 (pro-596 
inflammatory, antimicrobial response) and Treg (immune tolerance). Besides these 597 
balanced immunomodulatory activities, EcN MVs reinforce intestinal epithelial tight 598 
junctions. Thus, secreted MVs mediate the beneficial effects of this probiotic. Other 599 
commensal E. coli strains from the group B2 such as ECOR63 also have barrier 600 
strengthening activity and elicit similar Th responses but with a stronger pro-601 
inflammatory profile. Concerning the commensal strain ECOR12, secreted MVs mainly 602 
contribute to maintaining host tolerance against gut microbes by increasing the 603 
Treg/Th17 balance and protecting gut integrity by activating the Th22 response. In 604 
contrast, ECOR12 MVs do not trigger appropriate Th1 responses against pathogens nor 605 
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 Figure Legends 803 
Fig. 1. Cryo-TEM observation of isolated MVs from the indicated E. coli strains. 804 
Representative images of plunge-frozen MVs are shown. All samples were enriched in 805 
the conventional outer membrane vesicles originating from the outer membrane of Gram-806 
negative bacteria, but low-abundant outer-inner membrane vesicles (O-IMVs) were also 807 
observed. The image in the last panel shows an O-IMVS, in which the double-bilayer 808 
membrane structure is well defined. Scale bars: 200 nm. 809 
Fig. 2. Maturation of DCs treated with MVs from the indicated probiotic and 810 
commensal E. coli strains.  Expression of CD14, CD83 and CD209 in mo-DCs exposed 811 
to bacterial MVs (10 µg/ml) for 24 h was analysed by flow cytometry. Untreated mo-812 
DCs were kept in DC medium as a control of immature DCs. (A) A representative panel 813 
of flow cytometry histograms is shown, where values of untreated mo-DCs are 814 
indicated in red and those from vesicle-treated DCs in light blue. Overlapping areas are 815 
visualized in dark blue. (B) Quantification of CD14, CD209 and CD83 expression. The 816 
graph shows fold-changes in the mean fluorescence intensity (mean ± SEM) of the 817 
respective marker expression compared to control DCs (dot line). Data are from three 818 
independent biological experiments (at least three donors) performed in triplicate. 819 
Statistical differences were evaluated by one-way ANOVA followed by Bonferroni’s 820 
test. *p <0.05 versus control DCs, #p <0.05 versus DCs stimulated with EcN MVs. 821 
Fig. 3. DC modulation by MVs from probiotic and gut resident E. coli strains. (A-I) 822 
Levels of INF-, IL-12, IL-18, IL-6, IL-23, IL-1β, TNF-, IL-10 and TGF-β secreted by 823 
mo-DCs following 24 h incubation with MVs (10 µg/ml) of the indicated strains. 824 
Untreated mo-DCs were kept in DC medium as a control (black bars). Data (mean ± 825 
SEM) are from three independent biological experiments (at least three donors) 826 
performed in triplicate. Statistical differences were evaluated by one-way ANOVA 827 
followed by Bonferroni’s test (normal distribution) or the Kruskal-Wallis followed by 828 
Dunn’s test (non-normal distribution). *p <0.05 versus control DCs, #p <0.05 versus 829 
DCs stimulated with EcN MVs. 830 
 831 
Fig. 4. Gene expression levels of selected cytokines by MV-stimulated DCs. Immature 832 
mo-DCs were challenged for 6 h with MVs (10 µg/ml) of the indicated strains. (A-D) 833 
Relative mRNA levels of IL-6, TNF-α, IL-10 and TGF-β were measured by RT-qPCR, 834 




































































biological experiments (at least three donors) performed in triplicate and are presented 836 
as fold-change compared to untreated control cells. Statistical differences were 837 
evaluated by one-way ANOVA followed by Bonferroni’s test. *p <0.05 versus control 838 
DCs, #p <0.05 versus DCs stimulated with EcN MVs. 839 
 840 
Fig. 5. MV-stimulated DCs modulate CD4
+
 T cell responses in a strain-specific manner. 841 
(A-H) Quantification of secreted INF-, IL-17, IL-22, IL-4, IL-5, IL-13, IL-10, TGF-β 842 
and TNF-α by 3-day cocultures of MV-stimulated DCs and allogenic CD4+ T cells at a 843 
DC:T cell ratio of 1:5. Parallel cocultures with untreated iDCs were processed as a 844 
control. (I) Ratio of TGF-β/IL-17 values. Data (mean ± SEM) are from three 845 
independent biological experiments performed in triplicate. Statistical differences were 846 
evaluated by one-way ANOVA followed by Bonferroni’s test (normal distribution) or 847 
the Kruskal-Wallis followed by Dunn’s test (non-normal distribution). *p <0.05 versus 848 
control DCs, #p <0.05 versus DCs stimulated with EcN MVs.   849 
 850 
Fig. 6. Quantification of the Th17 and Treg subsets induced by MV-stimulated DCs. 851 
(A-B) Flow cytometric analysis of CD4
+
 T cells co-incubated for 3 days with untreated 852 
mo-DCs (iDC) or mo-DCs primed with MVs of the indicated strains (10 μg/ml) at a 853 









) population. Representative dot plots of CD4
+ 
cells 855 
co-incubated with iDCs (control) or with EcN MV-stimulated DCS are shown for each 856 
cell subset analysis. The percentage of positive cells is indicated in each quadrant or 857 
box. (C) Data (mean ± SEM) from three-independent experiments performed in 858 
triplicate are expressed as fold-change increase in the percentage of positive T cells for 859 
Th17 or Treg specific markers induced by MV-stimulated DCs with respect control 860 
iDCs induced values (set as 1, dot line). Statistical differences were evaluated by one-861 
way ANOVA followed by Bonferroni’s test (normal distribution) *p <0.05 versus 862 
control DCs. 863 
 864 
Fig. 7. Intestinal epithelial cells modulate cytokine production from DCs. Mo-DCs were 865 
incubated for 24 h with supernatants collected from the basolateral membrane of 866 
polarized Caco-2 monolayers challenged with MVs (10 µg/ml) of the indicated strains. 867 




































































TNF-α and (C) IL-10 secreted levels were quantified in Caco-2 basolateral supernatants 869 
(black bars) and in conditioned DCs cultures (white bars). Data (mean ± SEM) are from 870 
three independent biological experiments performed in duplicate. Statistical differences 871 
were evaluated by one-way ANOVA followed by Bonferroni’s test (normal 872 
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Figure S1. Cell viability of mo-DCs stimulated for 24 h with MVs (10 μg/ml) of 
the indicated strains assessed by the MTT and trypan blue assays Values are 
means ± standard error from three independent experiments. 
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